Rho, a Fraction From Rhodiola crenulate, Ameliorates Hepatic Steatosis in Mice Models

Rho, a Fraction From Rhodiola crenulate, Ameliorates Hepatic Steatosis in Mice Models

The prevalence of non-alcoholic fatty liver disease (NAFLD), which is developed from hepatic steatosis, is increasing worldwide. However, no specific drugs for NAFLD have been approved yet. To observe the effects of Rho, a fraction from Rhodiola crenulate, on non-alcoholic hepatic steatosis, three m...

Full description

Bibliographic Details
Main Authors: Qin Yi, Puyang Sun, Juan Li, Siming Kong, Jinying Tian, Xuechen Li, Yanan Yang, Peicheng Zhang, Yuying Liu, Jingyan Han, Xiaolin Zhang, Fei Ye
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-03-01
Series:Frontiers in Physiology
Subjects:
a fraction from Rhodiola crenulate (Rho)
non-alcoholic fatty liver disease (NAFLD)
hepatic steatosis
insulin resistance
hepatic lipid metabolism
Online Access:http://journal.frontiersin.org/article/10.3389/fphys.2018.00222/full

Internet

http://journal.frontiersin.org/article/10.3389/fphys.2018.00222/full

Similar Items